Clinical data showed that ENO1 expression in metastatic lesions was higher than that in the primary lesions and that ENO1 upregulation was significantly correlated with the TNM stage and tumor differentiation grade, and predicted a poor prognosis in patients with HCC. The gene discussed is ENO1; the disease is neoplasm.